SUBSCRIBE

Big Pharma’s Worst Nightmare: One Shroom Trip Does What Their Pills Can’t

Rxa

One trip. Zero side effects. Fuck your SSRIs.

That’s the takeaway from a new study that’s got pharmaceutical execs sweating through their custom suits: a single dose of psilocybin—the magic shit in magic mushrooms—can rapidly relieve symptoms of obsessive-compulsive disorder.

Not manage.
Not suppress.
Relieve.

The cure isn’t coming. It’s illegal.

While the FDA jerks off over incremental drug approvals and the DSM grows thicker than a Bible, nature’s been sitting on the cure like it’s some kind of cosmic prank. This isn’t some fringe-dwelling hippie bullshit, either. It’s double-blind, placebo-controlled science, motherfuckers.

They gave participants with moderate to severe OCD a single dose of synthetic psilocybin. Within HOURS, their obsessions and compulsions dropped like corporate accountability during a crisis.

One mushroom trip could wipe out an entire industry of mediocrity.

Rxa

Think about that. No daily pill reminders. No monthly check-ins to adjust dosage. No serotonin roulette wheel. Just one guided trip and people remembered what freedom felt like.

Big Pharma’s been selling suffering on subscription. Psilocybin just dropkicked the entire business model into a ditch.

Of course it’s still illegal—truth always is.

Why would the system legalize something that works too well? That doesn’t get you hooked? That makes you ask bigger, scarier questions than “Where’s my refill?” Psychedelics aren’t dangerous to your health. They’re dangerous to power.

OCD sufferers don’t need another chemical leash. They need a fucking lifeboat—and psilocybin looks like it floats.

Your mental health shouldn’t be profitable.

But until the suits can figure out how to put nature in a patent bottle, they’ll keep throwing pills at the problem and calling it “progress.” Meanwhile, the cure is growing quietly in cow shit, waiting for the next outlaw healer to set it free.

Rxa
THIS ISN’T A NEWSLETTER. IT’S A MIDDLE FINGER.
UNFUCK YOUR FEED.
SUBSCRIBE